Stripe, Anthropic and OpenAI are backing an effort to stop respiratory infections
TL;DR
Stripe, Anthropic and the OpenAI Foundation are backing Intercept, a new $500 million initiative aimed at respiratory infections. The program plans to fund early work on vaccines, nasal sprays, pills and air-cleaning systems before larger pharma companies take over costly development. Other supporters include Flu Lab, Bill Gates and people linked to Jane Street; Stripe public-goods lead Nan Ransohoff is co-leading the effort.
Nauti's Take
The ambition is huge, maybe too huge: colds and respiratory infections will not disappear just because Stripe, Anthropic and OpenAI put money behind a program. Still, the strategy is smarter than another narrow pandemic response because it connects everyday illness, indoor air and early biotech risk.
The PR layer is obvious, but the useful part is clear: fewer grand claims, more proof-of-concept work, real buyers and measurable adoption.
Briefingshow
Respiratory infections are not just a health issue; they hit productivity, schools and public infrastructure. Intercept is notable because it targets both medical products and cleaner indoor air. The real test is not the famous tech backers, but whether early projects become credible enough for pharma, employers and institutions to scale them.
Sources